Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer
Clinical trial NCT03168139 · COMPLETED
Trial details
- NCT number
- NCT03168139
- Sponsor
- TME Pharma AG
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-18
- Primary completion
- 2020-03-25
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.